Kitware and UNC Aim to Bring Robotic Stroke Care Closer to Patients
UNC School of Medicine supports robotic stroke innovation to help advance care for patients experiencing brain blood vessel disorders.
UNC School of Medicine supports robotic stroke innovation to help advance care for patients experiencing brain blood vessel disorders.
The Mathers Foundation, a highly selective national funder of innovative basic biomedical research, is supporting Thaxton’s work on a discovery that has the potential to transform human health.
Biology, Cancer, News, Oncology, Physiology, Research, Vital Signs
Researchers will develop and implement new strategies to address common barriers to care and reach patients due for cancer screenings for breast, colorectal, lung, and/or cervical cancers.
UNC School of Medicine’s Donna Evon, PhD, will lead a multi-center study evaluating a mind-body digital health program with and without clinician-guided psychotherapy to improve mental health, fatigue and other…
Participants who followed a Mediterranean-style plan tailored for the Southeast not only kept weight off, but also ate better in ways that may help prevent chronic disease.
Researchers are investigating a new way to tackle bone cancer while minimizing toxicity typically associated with chemotherapy.
Backed by results from the OPTIMA trial, the Prosigna Breast Risk of Recurrence (ROR) test offers a new way to personalize treatment and reduce unnecessary chemotherapy for patients with breast…
Bioinformatics, Cancer, Genetics And Aging, News, Pathology and Laboratory Medicine, Research, Vital Signs
How a cancer is first discovered can shape what happens next, and new research shows that steps are needed to map out treatment for older adults diagnosed in the emergency…
UNC is the only medical institution in the world to use high frequency sound waves to inactivate brain tissue that causes epilepsy.
Clinical Research, Neurology, Research, Surgery, Vital Signs
Researchers conduct new patient registry and radiation therapy study to improve outcomes for patients at high risk of liver cancer and those with early-stage cancer, respectfully